Article
Brussels, Belgium-Maximum permitted levels of the color additive canthaxanthin in animal feed have been severely reduced by the European Union (EU) because of fears that it may damage eyesight.
4DMT releases positive topline interim data from Part 1 of the SPECTRA clinical trial
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Ashvattha Therapeutics secures $50M in financing to advance clinical trials
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Bausch + Lomb launches its enVista Aspire monofocal and toric IOLs in the European Union
Samsara Vision announces positive intermediate-term visual and safety outcomes of SING IMT 6 months post-surgery